The ICN Steering Board Meeting (SBM) and Annual General Meeting (AGM) held on November 28, 2023, were defining moments for our collective ICN path. Hosted graciously by Hong Kong University Clinical Trials Center (HKU CTC), these gatherings exceeded expectations.
The SBM, with 18 participants including 9 out of 10 SB members and 2 ICN Scientific Advisory Board members, focused on ICN’s future trajectory and member engagement strategies. Notably, the SB welcomed a new ICN member and a Scientific Advisory Board member, enriching our network. The subsequent AGM boasted nearly 50 attendees from 17 ICN member organizations, alongside 3 Scientific Advisory Board members, demonstrating unwavering commitment to driving the ICN vision forward.